Show simple item record

dc.contributor.authorRamos-Goni, JM
dc.contributor.authorOppe, M
dc.contributor.authorStolk, E
dc.contributor.authorShah, K
dc.contributor.authorKreimeier, S
dc.contributor.authorRivero-Arias, O
dc.contributor.authorDevlin, N
dc.date.accessioned2020-11-26T22:56:29Z
dc.date.available2020-11-26T22:56:29Z
dc.date.issued2020-04-16
dc.identifierpii: 10.1007/s40273-020-00909-3
dc.identifier.citationRamos-Goni, J. M., Oppe, M., Stolk, E., Shah, K., Kreimeier, S., Rivero-Arias, O. & Devlin, N. (2020). International Valuation Protocol for the EQ-5D-Y-3L. PHARMACOECONOMICS, 38 (7), pp.653-663. https://doi.org/10.1007/s40273-020-00909-3.
dc.identifier.issn1170-7690
dc.identifier.urihttp://hdl.handle.net/11343/252049
dc.description.abstractThe EQ-5D-Y-3L is a generic, health-related, quality-of-life instrument for use in younger populations. Some methodological studies have explored the valuation of children's EQ-5D-Y-3L health states. There are currently no published value sets available for the EQ-5D-Y-3L that are appropriate for use in a cost-utility analysis. The aim of this article was to describe the development of the valuation protocol for the EQ-5D-Y-3L instrument. There were several research questions that needed to be answered to develop a valuation protocol for EQ-5D-Y-3L health states. Most important of these were: (1) Do we need to obtain separate values for the EQ-5D-Y-3L, or can we use the ones from the EQ-5D-3L? (2) Whose values should we elicit: children or adults? (3) Which valuation methods should be used to obtain values for child's health states that are anchored in Full health = 1 and Dead = 0? The EuroQol Research Foundation has pursued a research programme to provide insight into these questions. In this article, we summarized the results of the research programme concluding with the description of the features of the EQ-5D-Y-3L valuation protocol. The tasks included in the protocol for valuing EQ-5D-Y-3L health states are discrete choice experiments for obtaining the relative importance of dimensions/levels and composite time-trade-off for anchoring the discrete choice experiment values on 1 = Full Health and 0 = Dead. This protocol is now available for use by research teams to generate EQ-5D-Y-3L value sets for their countries allowing the implementation of a cost-utility analysis for younger populations.
dc.languageEnglish
dc.publisherADIS INT LTD
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0
dc.titleInternational Valuation Protocol for the EQ-5D-Y-3L
dc.typeJournal Article
dc.identifier.doi10.1007/s40273-020-00909-3
melbourne.affiliation.departmentMelbourne School of Population and Global Health
melbourne.source.titlePharmacoEconomics
melbourne.source.volume38
melbourne.source.issue7
melbourne.source.pages653-663
dc.rights.licensecc-by-nc
melbourne.elementsid1447137
melbourne.contributor.authorDevlin, Nancy
dc.identifier.eissn1179-2027
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record